Seoul, South Korea

Jae-Hoon Kang

USPTO Granted Patents = 16 


 

Average Co-Inventor Count = 5.6

ph-index = 2

Forward Citations = 14(Granted Patents)


Company Filing History:


Years Active: 2000-2024

Loading Chart...
Loading Chart...
Loading Chart...
16 patents (USPTO):Explore Patents

Title: The Innovative Mind of Jae-Hoon Kang: A Pioneer in Pharmaceutical Patents

Introduction: Jae-Hoon Kang, an esteemed inventor based in Seoul, South Korea, has made significant contributions to the field of pharmaceuticals, holding an impressive 16 patents to his name. His work has largely focused on the development of innovative compounds aimed at treating various medical conditions, showcasing his commitment to enhancing healthcare solutions.

Latest Patents: Among Jae-Hoon Kang's most noteworthy patents are his developments in isoxazole derivatives and fusion proteins. One of his latest inventions, titled "Isoxazole derivatives as nuclear receptor agonists and uses thereof," outlines methods for treating or ameliorating metabolic diseases, cholestatic liver diseases, or organ fibrosis. This patent presents a pharmaceutical composition comprising isoxazole derivatives, designed to provide effective treatment options for patients.

Another significant patent from Kang involves a "Pharmaceutical composition for preventing and treating eye diseases," which includes a fusion protein combining a tissue-penetrating peptide with an anti-vascular endothelial growth factor (VEGF) agent. This innovative approach not only enhances the efficacy of the treatment but aims to overcome resistance often observed in conventional therapies.

Career Highlights: Jae-Hoon Kang has made substantial contributions to the pharmaceutical industry through his work with notable companies, including Il Dong Pharmaceutical Co., Ltd. and Ildong Pharm Co., Ltd. His roles in these companies have allowed him to develop groundbreaking technologies and pharmaceutical compositions that address critical health challenges.

Collaborations: Throughout his career, partnering with talented individuals has been a key aspect of Kang's success. He has collaborated with esteemed coworkers such as Hong-Sub Lee and Kyung-Mi An, contributing to the advancement of medical research and development. These collaborations have further enriched his work, fostering a creative environment for innovation.

Conclusion: Jae-Hoon Kang's dedication to innovation in the pharmaceutical sector is exemplified by his extensive patent portfolio and collaborative efforts. With a focus on addressing pressing health issues, his patents have the potential to significantly impact the future of medical treatments. His work not only highlights his inventiveness but also serves as an inspiration for future generations of inventors in the field.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…